Tasquinimod slows tumour growth
Sunday, June 13th, 2010 Posted in prostate cancer | No Comments »U.S. researchers say a multi-center drug trial has shown the blood vessel-blocking drug tasquinimod is good in slowing the progression of prostate cancer. The scientists said tasquinimod works by halting new blood vessel development around the tumor, thereby stabilizing the disease. ...
Early intervention best approach to prostate cancer treatment
Saturday, June 5th, 2010 Posted in prostate cancer | No Comments »An urologist at Baylor College of Medicine suggests early-stage intervention in prostate cancer is the best approach to treatment of the disease. Because prostate cancer, when caught in the early stages, is highly treatable and curable, it is recommended that men ...
A new way to kill a cancer cell: light therapy
Thursday, June 3rd, 2010 Posted in prostate cancer | No Comments »A chemistry professor at Washington State University is working on a better way - one that specifically targets prostate cancer cells and causes a type of natural death that spares surrounding tissues from damage. The scientific team is studying photodynamic therapy, ...
Sanofi prostate cancer drug shows 28 percent survival
Thursday, May 27th, 2010 Posted in prostate cancer | No Comments »The outcome of a final-stage trial showed that Sanofi-Aventis' cabazitaxel candidate prostate cancer drug combined with prednisone reduced the risk of death by 28 percent compared with another treatment The clinical trial results will be presented at the 2010 American Society ...
Gene fusion may be behind prostate cancer, not androgen receptors
Sunday, May 23rd, 2010 Posted in prostate cancer | No Comments »A new study at University of Michigan reveals.the main cause of prostate cancer could be the fusion of two genes and the subsequent abnormal prostate cell growth that results when receptors for the hormone androgen get blocked. Researchers suggest the ...
Provenge, another option for prostate cancer patients
Saturday, May 22nd, 2010 Posted in prostate cancer | No Comments »Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration (FDA). The drug offers hope for men (and their families) to potentially extend and improve the quality of life for those who are suffering ...
Exercise during and after prostate cancer treatment result in a better quality of life
Friday, May 21st, 2010 Posted in prostate cancer | No Comments »According to researchers at Henry Ford Hospital in Detroit, prostate cancer patients who regularly exercise during and after cancer treatment report having a better quality of life and being less fatigued. Exercise is a great alternative to patients combating fatigue and ...
What is the role of focal therapy in low-risk prostate cancer?
Tuesday, May 18th, 2010 Posted in prostate cancer | No Comments »A recent study aimed to review the rationale, patient selection criteria, diagnostic imaging, biopsy schemes, and treatment modalities available for the focal therapy of localized prostate cancer. Limitations of focal therapy include the inability to stage or grade the cancer(s) accurately, ...
An effective viral treatment for localized prostate cancer
Thursday, May 13th, 2010 Posted in prostate cancer | 1 Comment »Reovirus is a double-stranded RNA virus that is widespread in the environment. Under normal circumstances it appears to cause no significant illnesses in humans, but it does appear to infect and kill prostate cancer cells in laboratory studies while having ...
Medical options to help prostate cancer patients to get information
Tuesday, May 11th, 2010 Posted in prostate cancer | No Comments »The dreaded words "You have prostate cancer" often leave patients confused and often men have tremendous difficulties deciding about their treatment, which can add to needless distress and side effects. To help men and their families The Cancer Information Service Research ...